[Rapporto di ricerca] Si prevede che il mercato del trattamento delle malattie neurologiche rare raggiungerà i 13.830,96 milioni di dollari nel 2027 rispetto ai 7.300,12 milioni di dollari del 2019. Si stima che il mercato crescerà con un CAGR dell'8,5% nel periodo 2020-2027.< /h3>
Le malattie neurologiche che hanno meno opzioni diagnostiche e terapeutiche e che colpiscono un piccolo numero di popolazione sono definite malattie neurologiche rare. Queste malattie colpiscono il sistema nervoso, che comprende il cervello, il midollo spinale e tutti i nervi che attraversano il corpo umano. La sclerosi laterale amiotrofica (SLA), la distrofia muscolare di Duchenne e la malattia di Huntington sono alcuni esempi di rare condizioni neurologiche. Il mercato globale del trattamento delle malattie neurologiche rare è guidato da fattori quali la crescente prevalenza di malattie neurologiche rare, farmaci in fase di sviluppo favorevoli e solide attività di ricerca per il trattamento delle malattie neurologiche rare. Tuttavia, è probabile che gli elevati costi di trattamento per le malattie neurologiche rare abbiano un impatto negativo sulla crescita del mercato durante il periodo di previsione.
Trattamento regionale redditizio per le malattie neurologiche rare Mercati
Approfondimenti di mercato
Crescente prevalenza di malattie neurologiche rare
Nel mondo della medicina, le malattie neurologiche rare rappresentano un onere significativo per i sistemi sanitari in termini di diagnosi, trattamento e gestione delle malattie. Alcune delle malattie neurologiche rare maggiormente osservate comprendono la narcolessia, la sclerosi laterale amiotrofica, il morbo di Alzheimer, la sclerosi multipla, l'atrofia muscolare spinale (SMA), la distrofia muscolare di Duchenne e altre. Secondo un dato pubblicato dal National Institutes of Neurological Disorders and Stroke nel 2019, negli Stati Uniti sono state registrate 7.000 malattie neurologiche rare. Inoltre, secondo lo stesso studio, queste condizioni sono responsabili di un numero significativo di morbilità e mortalità.
Privazione del sonno, stress psicologico, difetto genetico ereditario, cambiamento improvviso nel ritmo del sonno e l’invecchiamento sono i principali fattori che accelerano la prevalenza delle malattie neurologiche rare. Considerando questi fattori, la popolazione anziana è altamente vulnerabile alle condizioni neurologiche. Ad esempio, secondo lo studio pubblicato su Annals of Neurology nel 2017, nel 2011 circa 100 milioni di abitanti degli Stati Uniti erano colpiti da questa rara malattia neurologica. Inoltre, queste malattie sono responsabili dell’aumento della morbilità e della disabilità, che incide sulla condizione economica del paese. Paese. Si prevede che i disturbi neurologici legati al sonno aumenteranno nei prossimi anni a causa del crescente invecchiamento della popolazione in tutto il mondo. Secondo i dati pubblicati dal National Institute of Health (NIH) nel 2019, circa 40 milioni di americani soffrono di malattie neurologiche negli Stati Uniti, mentre altri 20 milioni di persone soffrono occasionalmente di problemi di sonno.
Approfondimenti sulle indicazioni
In base alle indicazioni, il mercato del trattamento delle malattie neurologiche rare è segmentato in narcolessia, sclerosi laterale amiotrofica, morbo di Alzheimer, sclerosi multipla, atrofia muscolare spinale (SMA), distrofia muscolare di Duchene. e altre indicazioni. Il segmento della malattia di Alzheimer ha detenuto la quota maggiore del mercato nel 2019 e si stima che registrerà il CAGR più elevato sul mercato durante il periodo di previsione. La malattia rappresenta quasi il 60-80% di tutti i casi di demenza ed è ampiamente riscontrata tra la popolazione che invecchia.
Mercato globale del trattamento delle malattie neurologiche rare, per indicazione: 2018 e 2027
Approfondimenti sul tipo di farmaco
In base al tipo di farmaco, il mercato del trattamento delle malattie neurologiche rare è segmentato in composti organici e prodotti biologici. Il segmento dei prodotti biologici ha detenuto la quota maggiore del mercato nel 2019 e si stima che registrerà il CAGR più elevato sul mercato durante il periodo di previsione.
Distribution Channel Insights
In base al canale di distribuzione, il mercato del trattamento delle malattie neurologiche rare è segmentato in farmacie online, farmacie ospedaliere e farmacie al dettaglio. Il segmento delle farmacie ospedaliere ha detenuto la quota maggiore del mercato nel 2019, tuttavia, si stima che le farmacie al dettaglio registreranno il CAGR più elevato sul mercato durante il periodo di previsione.
Modalità di Approfondimenti sulla somministrazione
In base alla modalità di somministrazione, il mercato del trattamento delle malattie neurologiche rare è segmentato in orale e iniettabile. Il segmento orale ha detenuto la quota maggiore del mercato nel 2019 e si stima che registrerà il CAGR più elevato sul mercato durante il periodo di previsione
Approfondimenti strategici
La strategia di lancio dei prodotti e di approvazione della FDA viene comunemente adottata dalle aziende per espandere la propria presenza in tutto il mondo e soddisfare la crescente domanda. Questa strategia è più comunemente adottata dagli operatori di mercato al fine di espandere il proprio portafoglio di prodotti.
Gli operatori di mercato che operano nel mercato del trattamento delle malattie neurologiche rare adottano la strategia di collaborazioni per ampliare la base di clienti in tutto il mondo, che consente inoltre ai giocatori di mantenere il proprio marchio a livello globale.
Mercato globale del trattamento delle malattie neurologiche rare– Per indicazione
- Narcolessia
- Sclerosi laterale amiotrofica
- Morbo di Alzheimer
- Sclerosi multipla
- Atrofia muscolare spinale (SMA)
- Distrofia muscolare di Duchenne
- Altre indicazioni
Mercato globale del trattamento delle malattie neurologiche rare– Per tipo di farmaco
- Composti organici
- Prodotti biologici
Mercato globale del trattamento delle malattie neurologiche rare– Per canale di distribuzione
- Farmacie online
- Farmacie ospedaliere
- Farmacie al dettaglio
Mercato globale del trattamento delle malattie neurologiche rare – Per modalità di somministrazione
- Mercato del trattamento delle malattie neurologiche rare
- iniettabili
; Per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'Asia Pacifico
- Medio Oriente e Stati Uniti. Africa
- Sudafrica
- Arabia Saudita
- Emirati Arabi Uniti
- Resto del Medio Oriente e dell'Africa
- Sudamerica
- Brasile
- Argentina
- Resto del Sudamerica
Profili aziendali
- Allergan plc
- Bayer AG
- GlaxoSmithKline plc
- Johnson & Johnson Services Inc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd
- Takeda Farmaceutico
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies - Rare Neurological Disease Treatment Market
- Allergan plc
- Bayer AG
- GlaxoSmithKline plc
- Johnson & Johnson Services Inc
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd
- Takeda Pharmaceutical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Mar 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Mar 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)